These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 33289812)

  • 21. Clinic-Based Validation of Cerebrospinal Fluid Biomarkers with Florbetapir PET for Diagnosis of Dementia.
    Álvarez I; Aguilar M; González JM; Ysamat M; Lorenzo-Bosquet C; Alonso A; Tartari JP; Romero S; Diez-Fairen M; Carcel M; Pujalte F; Pastor P
    J Alzheimers Dis; 2018; 61(1):135-143. PubMed ID: 29154286
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Advances in the development of tau PET radiotracers and their clinical applications.
    Okamura N; Harada R; Furukawa K; Furumoto S; Tago T; Yanai K; Arai H; Kudo Y
    Ageing Res Rev; 2016 Sep; 30():107-13. PubMed ID: 26802556
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neuroimaging in Dementia.
    Staffaroni AM; Elahi FM; McDermott D; Marton K; Karageorgiou E; Sacco S; Paoletti M; Caverzasi E; Hess CP; Rosen HJ; Geschwind MD
    Semin Neurol; 2017 Oct; 37(5):510-537. PubMed ID: 29207412
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Current Status of
    Sarikaya I; Sarikaya A; Elgazzar AH
    J Nucl Med Technol; 2018 Dec; 46(4):362-367. PubMed ID: 30076253
    [No Abstract]   [Full Text] [Related]  

  • 25. The Network Degeneration Hypothesis: Spread of Neurodegenerative Patterns Along Neuronal Brain Networks.
    Drzezga A
    J Nucl Med; 2018 Nov; 59(11):1645-1648. PubMed ID: 30385641
    [No Abstract]   [Full Text] [Related]  

  • 26. Imaging of neurodegenerative cognitive and behavioral disorders: practical considerations for dementia clinical practice.
    Atri A
    Handb Clin Neurol; 2016; 136():971-84. PubMed ID: 27430453
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recommendations for the use of PET imaging biomarkers in the diagnosis of neurodegenerative conditions associated with dementia: SEMNIM and SEN consensus.
    Arbizu J; García-Ribas G; Carrió I; Garrastachu P; Martínez-Lage P; Molinuevo JL
    Rev Esp Med Nucl Imagen Mol; 2015; 34(5):303-13. PubMed ID: 26099942
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Automated assessment of FDG-PET for differential diagnosis in patients with neurodegenerative disorders.
    Nobili F; Festari C; Altomare D; Agosta F; Orini S; Van Laere K; Arbizu J; Bouwman F; Drzezga A; Nestor P; Walker Z; Boccardi M;
    Eur J Nucl Med Mol Imaging; 2018 Jul; 45(9):1557-1566. PubMed ID: 29721650
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Brain 18F-FDG-PET: Utility in the Diagnosis of Dementia and Epilepsy.
    Lotan E; Friedman KP; Davidson T; Shepherd TM
    Isr Med Assoc J; 2020 Mar; 22(3):178-184. PubMed ID: 32147984
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Brain FDG-PET: clinical use in dementing neurodegenerative conditions.
    Nobili F; Schmidt R; Carriò I; Frisoni GB
    Eur J Nucl Med Mol Imaging; 2018 Jul; 45(9):1467-1469. PubMed ID: 29687206
    [No Abstract]   [Full Text] [Related]  

  • 31. [Current and future prospects of nuclear medicine in dementia].
    Ito K; Inui Y; Kizawa T; Kimura Y; Kato T
    Rinsho Shinkeigaku; 2017 Sep; 57(9):479-484. PubMed ID: 28804110
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [18 FDG PET imaging of the brain in the analysis of a dementia syndrome].
    Golüke-Willemse GA; Csepán-Magyar R; Rijnders AJ
    Tijdschr Gerontol Geriatr; 2012 Oct; 43(5):265-9. PubMed ID: 23167069
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neuroimaging in Dementias.
    Mahalingam S; Chen MK
    Semin Neurol; 2019 Apr; 39(2):188-199. PubMed ID: 30925612
    [TBL] [Abstract][Full Text] [Related]  

  • 34. PET radiotracers for molecular imaging in dementia.
    Baskin A; Giannakopoulos P; Ratib O; Seimbille Y; Assal F; Perani D; Garibotto V
    Curr Radiopharm; 2013 Dec; 6(4):215-30. PubMed ID: 24283962
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neuroimaging of Diseases Causing Dementia.
    Masdeu JC
    Neurol Clin; 2020 Feb; 38(1):65-94. PubMed ID: 31761062
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular Imaging Insights into Neurodegeneration: Focus on Tau PET Radiotracers.
    Shah M; Catafau AM
    J Nucl Med; 2014 Jun; 55(6):871-4. PubMed ID: 24833492
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 18F-FDG PET Improves Diagnosis in Patients with Focal-Onset Dementias.
    Taswell C; Villemagne VL; Yates P; Shimada H; Leyton CE; Ballard KJ; Piguet O; Burrell JR; Hodges JR; Rowe CC
    J Nucl Med; 2015 Oct; 56(10):1547-53. PubMed ID: 26251415
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of (18)FDG PET and (11)C-PIB PET brain imaging on the diagnosis of Alzheimer's disease and other dementias in a regional memory clinic in Hong Kong.
    Shea YF; Ha J; Lee SC; Chu LW
    Hong Kong Med J; 2016 Aug; 22(4):327-33. PubMed ID: 27313272
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neuroimaging of Alzheimer's disease: focus on amyloid and tau PET.
    Matsuda H; Shigemoto Y; Sato N
    Jpn J Radiol; 2019 Nov; 37(11):735-749. PubMed ID: 31493197
    [TBL] [Abstract][Full Text] [Related]  

  • 40. White matter hyperintensities and neurodegenerative dementias.
    Sassi C
    Aging (Albany NY); 2019 May; 11(10):2912-2913. PubMed ID: 31102504
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.